Idogen is a research company. The company's business focus is on developing vaccines for the treatment of diseases that adversely affect the immune system. The vaccines are intended to be used in the cases where autoimmune diseases have occurred and after organ rejection, particularly in the cases where antibodies have been formed against the ingestion of the regular medication of the patient. The company was founded in 2008 and is based in Lund.

Kurser for Idogen AB

Lige nu

+/-
-0,08
%
-5,02%
Seneste
1,515
Højeste
1,59
Laveste
1,355
Volumen
195 286
Omsætning (SEK)
294 270
Værdi (MSEK)
73,5

Bestyrelse og direktion

Adm. direktør

  • Anders Karlsson

Bestyrelsesformand

  • Agneta Edberg

Bestyrelse

  • Christina Herder
  • Karin Hoogendoorn
  • Leif G Salford

Film

Kommende rapporter

  • 2019-10-22 Delårsrapport 2019-Q3

  • 2020-02-11 Bokslutskommuniké 2019